10-Q Filing

HealthLynked Corp CIK: 1680139 Q2 2017

Filing Information

Form Type	10-Q
Accession Number	`0001213900-17-008676`
Period End Date	20170630
Filing Date	20170814
Fiscal Year	2017
Fiscal Period	Q2
XBRL Instance	hlyk-20170630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 63 Income Statement 64 Cash Flow Statement 64 Stockholders Equity 15

Balance Sheet 63 line items

Line Item	Tag	Value	Unit	Period
Property, plant and equipment, net of accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$716.35K	USD	Point-in-time
Property, plant and equipment, net of accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$704.78K	USD	Point-in-time
Convertible notes payable, net of original issue discount and debt discount	`DebtInstrumentUnamortizedDiscountCurrent`	$68.46K	USD	Point-in-time
Convertible notes payable, net of original issue discount and debt discount	`DebtInstrumentUnamortizedDiscountCurrent`	$114.33K	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$19.14K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$58.72K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$29.78K	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$243.83K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	230.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	230.00M	shares	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$146.87K	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$144.60K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	230.00M	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$27.62K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	65.75M	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$43.55K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	70.12M	shares	Point-in-time
Deferred offering costs	`DeferredOfferingCosts`	-	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	65.75M	shares	Point-in-time
Deferred offering costs	`DeferredOfferingCosts`	$147.22K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	70.12M	shares	Point-in-time
Total Current Assets	`AssetsCurrent`	$249.13K	USD	Point-in-time
Common stock issuable, par value	`CommonStockIssuableIssuePrice`	$0.00	USD	Point-in-time
Common stock issuable, par value	`CommonStockIssuableIssuePrice`	$0.00	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$338.59K	USD	Point-in-time
Property, plant and equipment, net of accumulated depreciation of $716,351 and $704,785 as of June 30, 2017 and December 31, 2016, respectively	`PropertyPlantAndEquipmentNet`	$66.32K	USD	Point-in-time
Common stock issuable, shares	`CommonStockIssuableShares`	80,643.00	shares	Point-in-time
Property, plant and equipment, net of accumulated depreciation of $716,351 and $704,785 as of June 30, 2017 and December 31, 2016, respectively	`PropertyPlantAndEquipmentNet`	$70.84K	USD	Point-in-time
Common stock issuable, shares	`CommonStockIssuableShares`	447,338.00	shares	Point-in-time
Deposits	`DepositsAssetsNoncurrent`	$9.54K	USD	Point-in-time
Deposits	`DepositsAssetsNoncurrent`	$9.54K	USD	Point-in-time
Total Assets	`Assets`	$414.44K	USD	Point-in-time
Total Assets	`Assets`	$329.51K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$151.80K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$148.47K	USD	Point-in-time
Capital leases, current portion	`CapitalLeaseObligationsCurrent`	$18.35K	USD	Point-in-time
Capital leases, current portion	`CapitalLeaseObligationsCurrent`	$18.35K	USD	Point-in-time
Due to related party, current portion	`DueToRelatedPartiesCurrent`	$311.79K	USD	Point-in-time
Due to related party, current portion	`DueToRelatedPartiesCurrent`	$483.89K	USD	Point-in-time
Convertible notes payable, net of original issue discount and debt discount of $68,459 and $114,332 as of June 30, 2017 and December 31, 2016, respectively	`ConvertibleDebtCurrent`	$485.67K	USD	Point-in-time
Convertible notes payable, net of original issue discount and debt discount of $68,459 and $114,332 as of June 30, 2017 and December 31, 2016, respectively	`ConvertibleDebtCurrent`	$642.54K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$964.28K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$1.30M	USD	Point-in-time
Capital leases, long-term portion	`CapitalLeaseObligationsNoncurrent`	$30.58K	USD	Point-in-time
Capital leases, long-term portion	`CapitalLeaseObligationsNoncurrent`	$39.75K	USD	Point-in-time
Due to related party, long-term portion	`DueToRelatedPartiesNoncurrent`	$247.82K	USD	Point-in-time
Due to related party, long-term portion	`DueToRelatedPartiesNoncurrent`	$237.16K	USD	Point-in-time
Total Liabilities	`Liabilities`	$1.24M	USD	Point-in-time
Total Liabilities	`Liabilities`	$1.57M	USD	Point-in-time
Common stock, par value $0.0001 per share, 230,000,000 shares authorized, 70,120,305 and 65,753,640 shares issued and outstanding as of June 30, 2017 and December 31, 2016, respectively	`CommonStockValue`	$6.58K	USD	Point-in-time
Common stock, par value $0.0001 per share, 230,000,000 shares authorized, 70,120,305 and 65,753,640 shares issued and outstanding as of June 30, 2017 and December 31, 2016, respectively	`CommonStockValue`	$7.01K	USD	Point-in-time
Common stock issuable, $0.0001 par value; 447,338 and 80,643 shares as of June 30, 2017 and December 31, 2016, respectively	`CommonStockIssuableValue`	$35.44K	USD	Point-in-time
Common stock issuable, $0.0001 par value; 447,338 and 80,643 shares as of June 30, 2017 and December 31, 2016, respectively	`CommonStockIssuableValue`	$6.45K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.20M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.96M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-2.12M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-3.16M	USD	Point-in-time
Total Shareholders' Deficit	`StockholdersEquity`	$-1.16M	USD	Point-in-time
Total Shareholders' Deficit	`StockholdersEquity`	$-911.68K	USD	Point-in-time
Total Liabilities and Shareholders' Deficit	`LiabilitiesAndStockholdersEquity`	$329.51K	USD	Point-in-time
Total Liabilities and Shareholders' Deficit	`LiabilitiesAndStockholdersEquity`	$414.44K	USD	Point-in-time

Income Statement 64 line items

Line Item	Tag	Value	Unit	Period
Patient service revenue, net	`HealthCareOrganizationPatientServiceRevenue`	$1.02M	USD	2 Qtrs
Patient service revenue, net	`HealthCareOrganizationPatientServiceRevenue`	$516.80K	USD	1 Quarter
Patient service revenue, net	`HealthCareOrganizationPatientServiceRevenue`	$502.28K	USD	1 Quarter
Patient service revenue, net	`HealthCareOrganizationPatientServiceRevenue`	$992.92K	USD	2 Qtrs
Salaries and benefits	`LaborAndRelatedExpense`	$963.00K	USD	2 Qtrs
Salaries and benefits	`LaborAndRelatedExpense`	$360.70K	USD	1 Quarter
Salaries and benefits	`LaborAndRelatedExpense`	$495.13K	USD	1 Quarter
Salaries and benefits	`LaborAndRelatedExpense`	$701.12K	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$888.40K	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$319.86K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$635.16K	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$498.38K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$11.57K	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$5.86K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$10.09K	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$5.00K	USD	1 Quarter
Total Operating Expenses	`OperatingExpenses`	$1.35M	USD	2 Qtrs
Total Operating Expenses	`OperatingExpenses`	$685.57K	USD	1 Quarter
Total Operating Expenses	`OperatingExpenses`	$999.37K	USD	1 Quarter
Total Operating Expenses	`OperatingExpenses`	$1.86M	USD	2 Qtrs
(Loss) income from operations	`OperatingIncomeLoss`	$-482.57K	USD	1 Quarter
(Loss) income from operations	`OperatingIncomeLoss`	$-330.52K	USD	2 Qtrs
(Loss) income from operations	`OperatingIncomeLoss`	$-870.06K	USD	2 Qtrs
(Loss) income from operations	`OperatingIncomeLoss`	$-183.29K	USD	1 Quarter
Amortization of original issue and debt discounts on convertible notes	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	$-58.52K	USD	1 Quarter
Amortization of original issue and debt discounts on convertible notes	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	$-130.57K	USD	2 Qtrs
Amortization of original issue and debt discounts on convertible notes	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	-	USD	2 Qtrs
Amortization of original issue and debt discounts on convertible notes	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	-	USD	1 Quarter
Interest expense	`InterestExpense`	$10.98K	USD	2 Qtrs
Interest expense	`InterestExpense`	$5.98K	USD	1 Quarter
Interest expense	`InterestExpense`	$20.21K	USD	1 Quarter
Interest expense	`InterestExpense`	$37.80K	USD	2 Qtrs
Total other expenses	`NonoperatingIncomeExpense`	$-78.73K	USD	1 Quarter
Total other expenses	`NonoperatingIncomeExpense`	$-10.98K	USD	2 Qtrs
Total other expenses	`NonoperatingIncomeExpense`	$-168.37K	USD	2 Qtrs
Total other expenses	`NonoperatingIncomeExpense`	$-5.98K	USD	1 Quarter
Net loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-1.04M	USD	2 Qtrs
Net loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-341.51K	USD	2 Qtrs
Net loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-561.30K	USD	1 Quarter
Net loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-189.27K	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	2 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-189.27K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.04M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-341.51K	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-561.30K	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$-0.01	USD	2 Qtrs
Basic	`EarningsPerShareBasic`	-	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$-0.02	USD	2 Qtrs
Basic	`EarningsPerShareBasic`	$-0.01	USD	1 Quarter
Fully diluted	`EarningsPerShareDiluted`	-	USD	1 Quarter
Fully diluted	`EarningsPerShareDiluted`	$-0.02	USD	2 Qtrs
Fully diluted	`EarningsPerShareDiluted`	$-0.01	USD	2 Qtrs
Fully diluted	`EarningsPerShareDiluted`	$-0.01	USD	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	55.28M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	55.00M	shares	2 Qtrs
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	69.41M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	68.03M	shares	2 Qtrs
Fully diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	69.41M	shares	1 Quarter
Fully diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	68.03M	shares	2 Qtrs
Fully diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	55.00M	shares	2 Qtrs
Fully diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	55.28M	shares	1 Quarter

Cash Flow Statement 64 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-189.27K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.04M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-341.51K	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-561.30K	USD	1 Quarter
Depreciation	`DepreciationAndAmortization`	$11.57K	USD	2 Qtrs
Depreciation	`DepreciationAndAmortization`	$5.86K	USD	1 Quarter
Depreciation	`DepreciationAndAmortization`	$10.09K	USD	2 Qtrs
Depreciation	`DepreciationAndAmortization`	$5.00K	USD	1 Quarter
Stock based compensation, including amortization of prepaid fees	`EmployeeBenefitsAndShareBasedCompensation`	$74.89K	USD	2 Qtrs
Stock based compensation, including amortization of prepaid fees	`EmployeeBenefitsAndShareBasedCompensation`	$48.65K	USD	2 Qtrs
Amortization of original issue and debt discounts on convertible notes	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	$-58.52K	USD	1 Quarter
Amortization of original issue and debt discounts on convertible notes	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	$-130.57K	USD	2 Qtrs
Amortization of original issue and debt discounts on convertible notes	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	-	USD	2 Qtrs
Amortization of original issue and debt discounts on convertible notes	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	-	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-118.54K	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-2.27K	USD	2 Qtrs
Prepaid expenses and deposits	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-15.92K	USD	2 Qtrs
Prepaid expenses and deposits	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-37.61K	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$3.32K	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-92.44K	USD	2 Qtrs
Due to related party, current portion	`IncreaseDecreaseInDueToRelatedPartiesCurrent`	$16.49K	USD	2 Qtrs
Due to related party, current portion	`IncreaseDecreaseInDueToRelatedPartiesCurrent`	$8.49K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-809.64K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-184.33K	USD	2 Qtrs
Acquisition of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$7.05K	USD	2 Qtrs
Acquisition of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$4.20K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-4.20K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-7.05K	USD	2 Qtrs
Proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$520.00K	USD	2 Qtrs
Proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$299.00K	USD	2 Qtrs
Proceeds from issuance of convertible notes	`ProceedsFromConvertibleDebt`	-	USD	2 Qtrs
Proceeds from issuance of convertible notes	`ProceedsFromConvertibleDebt`	$100.00K	USD	2 Qtrs
Proceeds from related party loans	`ProceedsFromRelatedPartyDebt`	$176.50K	USD	2 Qtrs
Proceeds from related party loans	`ProceedsFromRelatedPartyDebt`	$177.47K	USD	2 Qtrs
Repayment of related party loans	`RepaymentsOfRelatedPartyDebt`	$11.19K	USD	2 Qtrs
Repayment of related party loans	`RepaymentsOfRelatedPartyDebt`	$34.65K	USD	2 Qtrs
Repayment of bank loan	`RepaymentsOfBankDebt`	-	USD	2 Qtrs
Repayment of bank loan	`RepaymentsOfBankDebt`	$29.10K	USD	2 Qtrs
Payments on capital leases	`RepaymentsOfDebtAndCapitalLeaseObligations`	$9.17K	USD	2 Qtrs
Payments on capital leases	`RepaymentsOfDebtAndCapitalLeaseObligations`	$9.17K	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$777.10K	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$402.58K	USD	2 Qtrs
Net increase (decrease) in cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-39.58K	USD	2 Qtrs
Net increase (decrease) in cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$214.05K	USD	2 Qtrs
Cash, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$19.14K	USD	Point-in-time
Cash, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$58.72K	USD	Point-in-time
Cash, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$29.78K	USD	Point-in-time
Cash, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$243.83K	USD	Point-in-time
Cash, end of period	`CashAndCashEquivalentsAtCarryingValue`	$19.14K	USD	Point-in-time
Cash, end of period	`CashAndCashEquivalentsAtCarryingValue`	$58.72K	USD	Point-in-time
Cash, end of period	`CashAndCashEquivalentsAtCarryingValue`	$29.78K	USD	Point-in-time
Cash, end of period	`CashAndCashEquivalentsAtCarryingValue`	$243.83K	USD	Point-in-time
Cash paid during the period for interest	`InterestPaid`	$2.49K	USD	2 Qtrs
Cash paid during the period for interest	`InterestPaid`	$699.00	USD	2 Qtrs
Cash paid during the period for income tax	`IncomeTaxesPaidNet`	-	USD	2 Qtrs
Cash paid during the period for income tax	`IncomeTaxesPaidNet`	-	USD	2 Qtrs
Fair value of warrants issued to extend maturity date of convertible notes payable, recognized as discount against convertible notes payable	`FairValueOfWarrantsIssuedToExtendMaturityDateOfConvertibleNotesPayable`	$7.51K	USD	2 Qtrs
Fair value of warrants issued to extend maturity date of convertible notes payable, recognized as discount against convertible notes payable	`FairValueOfWarrantsIssuedToExtendMaturityDateOfConvertibleNotesPayable`	-	USD	2 Qtrs
Fair value of warrants issued pursuant to Amended Investment Agreement	`FairValueOfWarrantsIssuedPursuantToAmendedInvestmentAgreement`	-	USD	2 Qtrs
Fair value of warrants issued pursuant to Amended Investment Agreement	`FairValueOfWarrantsIssuedPursuantToAmendedInvestmentAgreement`	$153.62K	USD	2 Qtrs
Common stock to be issued now issued	`CommonStockToBeIssuedNowIssued`	$45.00K	USD	2 Qtrs
Common stock to be issued now issued	`CommonStockToBeIssuedNowIssued`	-	USD	2 Qtrs
Fair value of warrants, beneficial conversion feature and original issue discount allocated to proceeds of convertible notes payable	`FairValueOfWarrantsBeneficialConversionFeatureAndOriginalIssueDiscount`	$66.19K	USD	2 Qtrs
Fair value of warrants, beneficial conversion feature and original issue discount allocated to proceeds of convertible notes payable	`FairValueOfWarrantsBeneficialConversionFeatureAndOriginalIssueDiscount`	-	USD	2 Qtrs

Stockholders Equity 15 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$-1.16M	USD	Point-in-time
Balance	`StockholdersEquity`	$-911.68K	USD	Point-in-time
Balance, Shares	`SharesOutstanding`	-	shares	Point-in-time
Sale of common stock	`StockIssuedDuringPeriodValueNewIssues`	$520.00K	USD	2 Qtrs
Fair value of warrants allocated to proceeds of convertible notes payable	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$73.70K	USD	2 Qtrs
Fair value of warrants issued pursuant to Amended Investment Agreement	`AdditionalPaidInCapitalWarrantsIssuedPursuantToAmendedInvestmentAgreement`	$153.62K	USD	2 Qtrs
Consultant fees payable with common shares and warrants	`StockToBeIssuedForConsultantFees`	$31.08K	USD	2 Qtrs
Shares and options issued pursuant to employee equity incentive plan	`StockIssuedDuringPeriodValueEmployeeBenefitPlan`	$11.17K	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-189.27K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.04M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-341.51K	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-561.30K	USD	1 Quarter
Balance	`StockholdersEquity`	$-1.16M	USD	Point-in-time
Balance	`StockholdersEquity`	$-911.68K	USD	Point-in-time
Balance, Shares	`SharesOutstanding`	-	shares	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.